Results 161 to 170 of about 251,619 (354)
Sense of control and likelihood of prescription drug misuse 10-years later among middle-aged and older adults. [PDF]
Miller SE, Hong JH, Almeida DM.
europepmc +1 more source
Aim The aim of this study was to develop a novel workflow to identify human urine biomarkers for drugs of abuse and new psychoactive substances. Metabolites of amphetamine, cocaine, LSD, MDMA, methamphetamine, THC, MDMB‐CHMICA, and MDPPP were first identified in a zebrafish embryo (ZE) metabolism study followed by comparison to most abundant human ...
Simon K. Wellenberg +7 more
wiley +1 more source
Trends in treated drug misuse in the Midland Health Board Area 1996-2000. Occasional Paper no. 3. [PDF]
This occasional paper contains information gathered by the National Drug Treatment Reporting System (NDTRS), an epidemiological database on treated drug misuse complied by the Drug Misuse Research Division (DMRD) of the Health Research Board (HRB).
Cahill, Paul +2 more
core
MISUSE OF ANTIBIOTICS AND OTHER DRUGS IN COVID PANDEMIC
Shraddha D Muneshwar Uddesh Tehare
openalex +2 more sources
Family history of substance use disorder and likelihood of prescription drug misuse in adults 50 and older. [PDF]
Schepis TS, Wastila L, McCabe SE.
europepmc +1 more source
Aim Problem‐based learning (PBL) is an established approach in medical, nursing, pharmacy and veterinary medicine education. This study describes the implementation and aims to evaluate the use of non‐linear slide decks as a method to deliver PBL as individualized student assessments within pharmacology education. This approach, originally developed in
Wendy R. Francis +2 more
wiley +1 more source
Immigration policies as political determinants of alcohol and drug misuse among US-born Latinos. [PDF]
M P, P MZ, Ke P, Sj S.
europepmc +1 more source
Clinical Presentation and Management of Acute Dystonia from Drug Abuse or Misuse in Adolescents and Young Adults: A Retrospective Cohort Study in Bangkok, Thailand [PDF]
Pootipong Wongveerasin +4 more
openalex +1 more source
Patient‐reported outcomes (PROs) are essential for assessing clinical benefit and tolerability from the patient's perspective. In oncology trials, PRO data analysis often involves responder and time‐to‐event analyses, which depend on predefined thresholds to determine clinically meaningful change.
Anna Margarete Maria Thurner +5 more
wiley +1 more source

